CLINICAL_TRIALS
trial_result
· 2021-05-17
Clinical Trial Update: Open Label Extension Study of PREOS [Phase 3]
Summary
Open-label extension study update for PREOS in osteoporosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED